Rephonic
Artwork for The Lancet Oncology in conversation with

The Lancet Oncology in conversation with

The Lancet Group
Cancer Care
Immunotherapy
Prostate Cancer
Public Health
Head and Neck Cancer
National Cancer Control Plans
Breast Cancer
Phase 3 Randomised Clinical Trials
Clinical Trials
Cancer Control
Artificial Intelligence
Oncology
Human Papillomavirus
Global Cancer Surgery
Diffuse Intracranial Glioma
Cancer Burden
Quality Of Life
Radiotherapy
Extranodal Extension
Cancer Research

Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicit... more

PublishesMonthlyEpisodes214Founded6 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for The Lancet Oncology in conversation with

Latest Episodes

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Hedvig Hricak (Memorial Sloan Kettering Cancer Center, New York, NY, USA) and Dr Zachary Ward (Harvard TH Chan School of Public Health, Boston, MA, USA) to discuss Cancer workforce—a... more

Cheryl Lai, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Fred Saad (Department of Surgery/Urology, University of Montreal, Montreal, QC, Canada) to discuss pain and health-related quality-of-life outcomes from the randomised ph... more

Cheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Professor James Nagarajah to discuss his open-label, randomised, phase 2 study [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE).

Click here to... more

Join us for this special episode where Deputy Editor Cheryl Lai speaks with Ali Landman, Editor-in-Chief of The Lancet Medical Imaging & Theranostics, about the scope and vision of the new journal and Ali's highlights in oncological imaging from the ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Fred Saad
Professor of Urology, Oncology, and prostate cancer and Chairman of the Department of Surgery at the University of Montreal
University of Montreal
Episode: Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
James Nagarajah
Professor of Radiology and Nuclear Medicine
Radboud University Medical Center, Netherlands
Episode: James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Ali Landman
Editor-in-Chief of The Lancet Medical Imaging & Theranostics
Lancet Group
Episode: Ali Landman on the European Congress of Radiology 2026
Kayleigh Bhangdia
A team member from the Institute for Health Metrics and Evaluation
Institute for Health Metrics and Evaluation (IHME)
Episode: Kayleigh Bhangdia on breast cancer GBD study 2023
Dr. Jesse Plascak
Associate Professor in the Division of Cancer Prevention and Control
The Ohio State University
Episode: Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers
Dr. Marissa Baker
Associate Professor in the University of Washington, Department of Environmental and Occupational Health Science
University of Washington
Episode: Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers
Dr. Gary Rodin
Expert from the University of Toronto discussing human aspects of cancer care
University of Toronto
Episode: Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission
Dr. Matthias Preusser
Professor of Medical Oncology and Head of the Division of Oncology at the Medical University of Vienna, Austria
Medical University of Vienna, Austria
Episode: Matthias Preusser on the phase 2 TUXEDO-3 trial
Dr. Andrea Necchi
Associate Professor at the Vita-Salute San Raffaele University and Director of Genitourinary Medical Oncology at the San Raffaele Hospital in Milan, Italy
Vita-Salute San Raffaele University, San Raffaele Hospital
Episode: Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer

Hosts

Cheryl Lai
Primary host with multiple appearances; editoring and hosting duties across oncology-related episodes.
Dr. Cheryl Reeves
Co-host appearing across episodes; editor and healthcare communications lead.
Jamie
Host contributing to conversations with authors and researchers.
Dr. Smriti Patodia
Senior Editor and recurring host/commentator on Lancet Oncology topics.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
Q: In the aeronaut study, did you find the patients were engaged and enthusiastic about completing the additional QoL questionnaires?
Yes, there was high compliance and engagement from patients and investigators, reflecting commitment to endpoints beyond the primary outcomes, even amid the challenges posed by the COVID-19 era.
Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
Q: Could you start, please, by telling us what led you to initiate the phase III AeroNote trial, and what was the treatment landscape like for patients with metastatic hormone-sensitive prostate cancer when the trial was designed?
Dr. Saad explains that darolutamide showed efficacy in non-metastatic settings and that prior data suggested combination strategies could improve outcomes; AeroNote was designed to test darolutamide alone added to ADT against ADT alone, with RPFS as the primary endpoint to shorten the study while building on known benefits.
James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Q: What makes 177Lu-PSMA-617 a promising treatment for oligometastatic hormone-sensitive prostate cancer and why evaluate it in hormone-sensitive disease?
It targets what is seen with theranostics, offering a favorable side-effect profile and potential applicability across disease stages, which supports exploring earlier intervention in hormone-sensitive oligometastatic disease and comparing its impact on progression-free endpoints like ADT-free survival.
Kayleigh Bhangdia on breast cancer GBD study 2023
Q: Hello, Kayleigh, could you give us a bit of a background on the Global Burden of Disease study and its main objectives?
The GBD study was created to systematically measure global health problems to provide comprehensive, comparable health metrics for policy making, expanding over time to include more conditions and data sources and to quantify health loss using measures like DALYs.
Dylan Graetz and Erica Kaye on qualitative research in oncology
Q: How might oncology professionals and other stakeholders help integrate qualitative methods?
Oncology professionals need to learn about qualitative methods and collaborate with qualitative researchers to enhance their research efforts.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Lancet Oncology in conversation with

What is The Lancet Oncology in conversation with about and what kind of topics does it cover?

This show features interviews with leading cancer researchers, clinicians, and editors, drawing out the practical implications of the latest oncology research for patients, care delivery, and health policy. Episodes often center on trial results, novel therapies, cancer imaging and diagnostics, and the human dimensions of cancer care, with hosts who are editors or researchers from The Lancet Oncology guiding the conversation. A standout strength is the breadth of topics—from prostate cancer outcomes and radioligand therapy to global cancer burden, qualitative research in oncology, and imaging-driven advances—paired with a clear eye toward how new evidence translates into better patient outcomes and system-level improvements. The format tend... more

Where can I find podcast stats for The Lancet Oncology in conversation with?

Rephonic provides a wide range of podcast stats for The Lancet Oncology in conversation with. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Lancet Oncology in conversation with and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Lancet Oncology in conversation with get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Lancet Oncology in conversation with, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Lancet Oncology in conversation with?

Rephonic provides comprehensive predictive audience data for The Lancet Oncology in conversation with, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Lancet Oncology in conversation with have?

To see how many followers or subscribers The Lancet Oncology in conversation with has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Lancet Oncology in conversation with?

These podcasts share a similar audience with The Lancet Oncology in conversation with:

1. NEJM This Week
2. JAMA Editors' Summary
3. Harrison's PodClass: Internal Medicine Cases and Board Prep
4. JAMA Medical News
5. Journal of Clinical Oncology (JCO) Podcast

How many episodes of The Lancet Oncology in conversation with are there?

The Lancet Oncology in conversation with launched 6 years ago and published 214 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Lancet Oncology in conversation with?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Lancet Oncology in conversation with?

Rephonic pulls ratings and reviews for The Lancet Oncology in conversation with from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Lancet Oncology in conversation with?

Rephonic provides full transcripts for episodes of The Lancet Oncology in conversation with. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Lancet Oncology in conversation with?

Recent guests on The Lancet Oncology in conversation with include:

1. Fred Saad
2. James Nagarajah
3. Ali Landman
4. Kayleigh Bhangdia
5. Dr. Jesse Plascak
6. Dr. Marissa Baker
7. Dr. Gary Rodin
8. Dr. Matthias Preusser

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days